An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.

DUI

D001545 MeSH Prohlížeč

CUI

M0002315

CAS

DL-Serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide

Předchozí užití

Benzene (1966-1967); Benzene Derivatives (1968-1971); Benzyl Compounds (1972); Hydrazines (1966-1972); Serine (1966-1972)

Historická pozn.

91(79); was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1973-78 (Prov 1973-74)

Online pozn.

use BENSERAZIDE to search SERYLTRIHYDROXY BENZYLHYDRAZINE 1973-78 (as Prov 73-74)

Veřejná pozn.

91; was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1975-78